These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 18812017

  • 1. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations.
    Brixner DI, Jackson KC, Sheng X, Nelson RE, Keskinaslan A.
    Curr Med Res Opin; 2008 Sep; 24(9):2597-607. PubMed ID: 18812017
    [Abstract] [Full Text] [Related]

  • 2. Valsartan plus hydrochlorothiazide: a review of its use since its introduction.
    Bains J, Smith WB.
    Expert Opin Pharmacother; 2011 Aug; 12(12):1975-84. PubMed ID: 21728903
    [Abstract] [Full Text] [Related]

  • 3. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC, Sheng X, Nelson RE, Keskinaslan A, Brixner DI.
    Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
    [Abstract] [Full Text] [Related]

  • 4. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Aug; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 6. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R, Handrock R, Klebs S, Tousset E, Vrijens B.
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [Abstract] [Full Text] [Related]

  • 7. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 15; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul 15; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 10. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho B, Ueng KC, DiTommaso S, Shete A.
    Vasc Health Risk Manag; 2015 Jul 15; 11():71-8. PubMed ID: 25653536
    [Abstract] [Full Text] [Related]

  • 11. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV, Remigio-Baker RA, Thiebaud P, Preblick R, Plauschinat C.
    BMC Fam Pract; 2008 Nov 06; 9():61. PubMed ID: 18990240
    [Abstract] [Full Text] [Related]

  • 12. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH.
    Curr Med Res Opin; 2015 Dec 06; 31(12):2287-96. PubMed ID: 26397178
    [Abstract] [Full Text] [Related]

  • 13. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Barrios V, Escobar C.
    Expert Rev Cardiovasc Ther; 2010 Nov 06; 8(11):1609-18. PubMed ID: 21090936
    [Abstract] [Full Text] [Related]

  • 14. Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies.
    Nash DT, Crikelair N, Zappe D.
    Curr Med Res Opin; 2008 Sep 06; 24(9):2617-26. PubMed ID: 18687165
    [Abstract] [Full Text] [Related]

  • 15. Valsartan plus hydrochlorothiazide for first-line therapy in hypertension.
    Lacourcière Y, Poirier L, Samuel R.
    Expert Rev Cardiovasc Ther; 2009 Dec 06; 7(12):1491-501. PubMed ID: 19954310
    [Abstract] [Full Text] [Related]

  • 16. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR.
    Chronobiol Int; 2011 Aug 06; 28(7):601-10. PubMed ID: 21823969
    [Abstract] [Full Text] [Related]

  • 17. Valsartan/hydrochlorothiazide: a review of its use in the management of hypertension.
    Wagstaff AJ.
    Drugs; 2006 Aug 06; 66(14):1881-901. PubMed ID: 17040120
    [Abstract] [Full Text] [Related]

  • 18. Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
    Zappe DH, Sowers JR, Hsueh WA, Haffner SM, Deedwania PC, Fonseca VA, Keeling L, Sica DA.
    J Clin Hypertens (Greenwich); 2008 Dec 06; 10(12):894-903. PubMed ID: 19120715
    [Abstract] [Full Text] [Related]

  • 19. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks.
    Prescrire Int; 2011 Mar 06; 20(114):67. PubMed ID: 21648225
    [No Abstract] [Full Text] [Related]

  • 20. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED.
    Am J Cardiovasc Drugs; 2009 Mar 06; 9(6):411-8. PubMed ID: 19929039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.